This inventor holds 7 USPTO granted patents and 12 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2017-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2026
Title: The Innovative Contributions of Shephard Mpofu in Inflammatory Arthritis Treatment
Introduction
Shephard Mpofu is a prominent inventor based in Oberwil, Switzerland, known for his groundbreaking work in the field of inflammatory arthritis treatment. With a total of four patents to his name, Mpofu is recognized for developing innovative therapies that leverage Interleukin-17 (IL-17) antagonists, which have the potential to significantly improve patient outcomes.
Latest Patents
Mpofu's latest patents focus on novel methods for treating ankylosing spondylitis and psoriatic arthritis using IL-17 antagonists. One of his recent disclosures covers methods of treating inflammatory arthritis, specifically psoriatic arthritis, by employing therapeutically effective amounts of IL-17 antagonists, such as IL-17 binding molecules like secukinumab. Another important patent details the use of IL-17 antagonists to inhibit the progression of structural damage in psoriatic arthritis patients, encompassing a range of methods, medicaments, and kits designed to enhance treatment efficacy.
Career Highlights
As a key member of Novartis AG, Mpofu has made significant strides in biotechnology and pharmaceutical research. His state-of-the-art discoveries in the management of inflammatory diseases underscore his commitment to clinical innovation and the advancement of patient care. His patents reflect a deep understanding of immunology and the complexities of arthritic conditions.
Collaborations
Throughout his career, Shephard Mpofu has collaborated with notable colleagues, including Hanno Richards and Karthinathan Thangavelu. These partnerships have fostered a rich environment for innovation and have been instrumental in the successful development of therapies aimed at improving the lives of patients suffering from chronic inflammatory conditions.
Conclusion
Shephard Mpofu stands out as a visionary inventor whose work has the potential to reshape treatment paradigms for patients with inflammatory arthritis. His innovative patents not only highlight his expertise but also signify a dedication to advancing medical science for better health outcomes. Through his contributions at Novartis AG and collaborations with fellow researchers, Mpofu continues to make a lasting impact in the field of biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile